A Phase 3 Extension Study of Duvelisib and Ofatumumab in Participants With CLL/SLL Previously Enrolled in Study IPI-145-07
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
69 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Facility name not stated
Bedford Park, Australia
- Facility name not stated
East Melbourne, Australia
- Facility name not stated
Melbourne, Australia
- Facility name not stated
Linz, Austria
- Facility name not stated
Vienna, Austria
- Facility name not stated
Vienna, Austria
- Facility name not stated
Wels, Austria
- Facility name not stated
Brussels, Belgium
- Facility name not stated
Brussels, Belgium
- Facility name not stated
Ghent, Belgium
- Facility name not stated
Leuven, Belgium
- Facility name not stated
Sint-Niklaas, Belgium
- Facility name not stated
Argenteuil, France
- Facility name not stated
Bobigny, France
- Facility name not stated
Bordeaux, France
- Facility name not stated
Caen, France
- Facility name not stated
Clermont-Ferrand, France
- Facility name not stated
La Roche-sur-Yon, France
- Facility name not stated
Limoges, France
- Facility name not stated
Nantes, France
- Facility name not stated
Rennes, France
- Facility name not stated
Vandœuvre-lès-Nancy, France
- Facility name not stated
Berlin, Germany
- Facility name not stated
Leer, Germany
- Facility name not stated
Ulm, Germany
- Facility name not stated
Budapest, Hungary
- Facility name not stated
Budapest, Hungary
- Facility name not stated
Debrecen, Hungary
- Facility name not stated
Győr, Hungary
- Facility name not stated
Kaposvár, Hungary
- Facility name not stated
Pécs, Hungary
- Facility name not stated
Szeged, Hungary
- Facility name not stated
Catania, Italy
- Facility name not stated
Lecce, Italy
- Facility name not stated
Meldola, Italy
- Facility name not stated
Milan, Italy
- Facility name not stated
Milan, Italy
- Facility name not stated
Padova, Italy
- Facility name not stated
Ravenna, Italy
- Facility name not stated
Rimini, Italy
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Dec 2013
- Primary completion
- 12 Jun 2020
- Completion
- 12 Jun 2020
- Last update posted
- 21 Sept 2023
- Registered enrollment
- 99
- Registry id
- NCT02049515
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.